STOCK TITAN

Ealixir (EAXR) S-1 Filings

EAXR OTC

Here are the S-1 registration statements from Ealixir Inc (EAXR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An S-1 covers the registration statement a company files to sell shares publicly, so if you follow EAXR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EAXR filings page.

Rhea-AI Summary

Ealixir, Inc. (EAXR) is registering for resale up to 22,602,658 shares of common stock held by selling stockholders. Ealixir will receive no proceeds from their sales. The prospectus lists 60,121,536 shares outstanding before and after the resale, based on the count as of October 19, 2026.

While the stock is quoted on OTC Pink, selling stockholders will offer the shares at a fixed price per share. If and when the stock is quoted on a national securities exchange, they may sell at prevailing market prices, privately negotiated prices, or in transactions outside the public market. Ealixir intends to implement a reverse split after the offering closes, at a ratio ranging from one share for every two existing shares to one share for every four existing shares; the Board will choose the ratio, and authorized common stock will be reduced by the same ratio.

For 2025, revenue was $3,582,693 and net income was $101,682, compared with revenue of $3,356,771 and a net loss of $264,815 in 2024. Ealixir also reported a net loss of $101,940 for the quarter ended June 30, 2026. Its auditor’s 2025 report includes an explanatory paragraph expressing substantial doubt about Ealixir’s ability to continue as a going concern.

Rhea-AI Summary

Ealixir, Inc. is registering 22,602,658 shares of common stock for resale by existing stockholders. All shares are being sold by selling stockholders, so the company will not receive any proceeds from these sales.

Ealixir provides online reputation management services focused on the “right to be forgotten,” removing or deindexing harmful content and creating positive content for individuals and businesses. In 2025 it generated $3.58 million in revenue and modest net income of $101,682, but still reported a stockholders’ deficit and its auditor raised substantial doubt about its ability to continue as a going concern. The company operates as an emerging growth and smaller reporting company, trades on the OTC Pink under “EAXR,” and plans to seek a national exchange listing, while control remains highly concentrated with its CEO, who holds about 93.7% of voting power.

Rhea-AI Summary

Ealixir, Inc. has filed a Form S-1 to register up to 22,602,658 shares of common stock for resale by existing selling stockholders. This is a secondary offering, so the company will not receive proceeds from these sales; selling holders will receive any sale proceeds.

The company’s common stock trades on the OTC Pink under the symbol “EAXR,” with a last reported price of $1.30 per share on April 29, 2026. Ealixir is an emerging growth and smaller reporting company focused on online reputation management, reporting 2025 revenue of $3.58 million and net income of $101,682 despite a continued stockholders’ deficit.